Skip to main content
Journal ArticleOPEN ACCESS

ATNT-05INTRAOPERATIVE INTRAPARENCHYMAL INJECTION OF IRINOTECAN DRUG LOADED BEADS IN PATIENTS WITH RECURRENT GLIOBLASTOMA (GBM): A SAFE NEW DEPOT APPROACH FOR LOCO-REGIONAL THERAPY (NCT02433392)

  • Cruickshank G
  • Fayeye O
  • Ngoga D
  • et al.
Neuro-Oncology (2015) 17(suppl 5) v11.1-v11
DOI: 10.1093/neuonc/nov205.05
N/ACitations
Citations of this article
16Readers
Mendeley users who have this article in their library.

Abstract

TR-14. A FEASIBILITY AND RANDOMIZED PHASE II STUDY OF VORINOSTAT, BEVACIZUMAB, OR TEMOZOLOMIDE DURING RADIATION FOLLOWED BYMAINTENANCE CHEMOTHERAPY IN NEWLY-DIAGNOSED PEDIATRIC HIGH-GRADE GLIOMA: CHILDREN’S ONCOLOGY GROUP STUDY ACNS0822

Cite

CITATION STYLE

APA

Cruickshank, G., Fayeye, O., Ngoga, D., Connor, J., & Detta, A. (2015). ATNT-05INTRAOPERATIVE INTRAPARENCHYMAL INJECTION OF IRINOTECAN DRUG LOADED BEADS IN PATIENTS WITH RECURRENT GLIOBLASTOMA (GBM): A SAFE NEW DEPOT APPROACH FOR LOCO-REGIONAL THERAPY (NCT02433392). Neuro-Oncology, 17(suppl 5), v11.1-v11. https://doi.org/10.1093/neuonc/nov205.05

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free